Immuneering Corporation

1.48
-0.17 (-10.30%)
At close: Mar 03, 2025, 3:59 PM
1.48
0.09%
After-hours: Mar 03, 2025, 07:03 PM EST

Immuneering Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 59.41M 72.64M 74.89M 37.09M 13.78M
Short-Term Investments 26.26M 32.89M 74.31M n/a n/a
Long-Term Investments n/a n/a 996.56K n/a n/a
Other Long-Term Assets 1.03M 743.7K 102.13K -31.92K -21.8K
Receivables n/a 12.42K 246.04K 500.11K 209.94K
Inventory n/a 1.00 n/a n/a n/a
Other Current Assets 3.42M 3.21M 2.89M 140.96K 71.22K
Total Current Assets 89.08M 108.75M 152.33M 37.73M 14.06M
Property-Plant & Equipment 5.4M 5.78M 6.13M 677.47K 35.28K
Goodwill & Intangibles 7.07M 7.1M 7.14M n/a n/a
Total Long-Term Assets 13.5M 13.62M 14.37M 691.8K 35.28K
Total Assets 102.58M 122.37M 166.7M 38.42M 14.1M
Account Payables 2.11M 3.15M 1.39M 1.48M 294.95K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 300.11K 378.72K 274.04K 76.32K n/a
Other Current Liabilities 5.43M 4.52M 3.97M 698.99K 210.35K
Total Current Liabilities 7.85M 8.05M 5.63M 2.26M 505.3K
Long-Term Debt 4.16M 4.46M 5.09M 544.77K 16.61M
Other Long-Term Liabilities n/a n/a n/a 58.1M 3.51M
Total Long-Term Liabilities 4.16M 4.46M 5.09M 58.65M 20.12M
Total Liabilities 12.01M 12.52M 10.72M 60.9M 20.63M
Total Debt 4.46M 4.84M 5.36M 621.09K 16.61M
Common Stock 29.27K 26.42K 26.32K 4.95K 4.95K
Retained Earnings -163.26M -109.79M -59.27M -25.74M -8.7M
Comprehensive Income -778 -30.12K -49.01K -58.1M -16.61M
Shareholders Equity 90.58M 109.85M 155.98M -22.48M -6.53M
Total Investments 26.26M 32.89M 75.31M n/a n/a